Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Curida Holding

Curida Holding?uq=WouuG6Ev
PRIVATE STATUS
101-200 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$3.15M LATEST DEAL AMOUNT
3 INVESTORS
Description

Operator of a Contract Development and Manufacturing Organization. The company has a core competency in the state-of-the-art manufacturing of Liquid Pharmaceuticals based on sterile unit-dose Blow-Fill-Seal (BFS) technology and Nasal Spray.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Solb√¶rvegen 5
  • 2409 Elverum
  • Norway
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Curida Holding’s full profile, request a free trial.

Curida Holding Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 19-Jan-2018 $3.15M 00.00 Completed Generating Revenue
1. Early Stage VC 22-Dec-2017 00.000 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Curida Holding Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Investinor Venture Capital Minority 000 0000 000000 0
Canica PE/Buyout Minority 000 0000 000000 0
Torvald Klaveness Corporation Minority 000 0000 000000 0

Curida Holding Executive Team (3)

Name Title Board
Seat
Contact
Info
Leif Skymoen Chief Executive Officer
Terje Gabrielsen Chief Financial Officer
Per Thoresen Chairman

Curida Holding Board Members (2)

Name Representing Role Since Contact
Info
Ann-Tove Kongsnes Investinor Board Member 000 0000
Per Thoresen Curida Holding Chairman 000 0000